<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7094090/table_5" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 5</label>
  <title>Selected Patents Associated with Potential Drugs (Repurposing) for COVID-19 or Small Molecules for Treatment of SARS or MERS</title>
 </caption>
 <colgroup>
  <col align="left"/>
  <col align="left"/>
  <col align="left"/>
  <col align="left"/>
 </colgroup>
 <thead>
  <tr>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-0-.">patent no.</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-1-.">priority date</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-2-.">title</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-3-.">organization</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td style="border:none;" align="left">WO2009114512</td>
   <td style="border:none;" align="left">20080311</td>
   <td style="border:none;" align="left">Preparation of azetidine and cyclobutane derivatives as JAK inhibitors</td>
   <td style="border:none;" align="left">Incyte Corporation, USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2014028756</td>
   <td style="border:none;" align="left">20140220</td>
   <td style="border:none;" align="left">Deuterated baricitinib</td>
   <td style="border:none;" align="left">Concert Pharmaceuticals, Inc., USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">JP5971830</td>
   <td style="border:none;" align="left">20150428</td>
   <td style="border:none;" align="left">Preparation of polycyclic pyridone derivatives as cap-dependent endonuclease (CEN) inhibitors and prodrugs thereof</td>
   <td style="border:none;" align="left">Shionogi and Co., Ltd., Japan</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">US20160122374</td>
   <td style="border:none;" align="left">20141029</td>
   <td style="border:none;" align="left">Preparation of nucleosides and methods for treating Filoviridae virus infections</td>
   <td style="border:none;" align="left">Gilead Sciences, Inc., USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">US20170071964</td>
   <td style="border:none;" align="left">20160916</td>
   <td style="border:none;" align="left">Preparation of amino acid-containing nucleotides and methods for treating arenaviridae and coronaviridae virus infections</td>
   <td style="border:none;" align="left">Gilead Sciences, Inc., USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2007075145</td>
   <td style="border:none;" align="left">20070704</td>
   <td style="border:none;" align="left">Preparation of benzopyranone derivatives as anti-coronaviral agents</td>
   <td style="border:none;" align="left">Singapore Polytechnic, Singapore; Shanghai Institute of Materia Medica Chinese Academy of Sciences, China</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2005021518</td>
   <td style="border:none;" align="left">20050310</td>
   <td style="border:none;" align="left">Preparation of 3,4-dihydro-2 
    <i>H</i>-1,4-benzoxazine-2-carboxylic acid derivatives as cysLT2 receptor antagonists for treatment of respiratory diseases 
   </td>
   <td style="border:none;" align="left">Ono Pharmaceutical Co., Ltd., Japan</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2007120160</td>
   <td style="border:none;" align="left">20071025</td>
   <td style="border:none;" align="left">Preparation of N-heterocyclic acetamides useful for viral inhibition</td>
   <td style="border:none;" align="left">Novartis AG, USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2009119167</td>
   <td style="border:none;" align="left">20091001</td>
   <td style="border:none;" align="left">Aniline derivative having anti-RNA viral activity</td>
   <td style="border:none;" align="left">KinoPharma, Inc., Japan</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2013049382</td>
   <td style="border:none;" align="left">20130404</td>
   <td style="border:none;" align="left">Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses</td>
   <td style="border:none;" align="left">Kansas State University Research Foundation; The Ohio State University; Wichita State University -Â all in USA</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2018042343</td>
   <td style="border:none;" align="left">20180308</td>
   <td style="border:none;" align="left">Preparation of peptides that inhibit 3C and 3CL proteases and methods of use thereof</td>
   <td style="border:none;" align="left">GlaxoSmithKline, UK</td>
  </tr>
  <tr>
   <td style="border:none;" align="left">WO2007067515</td>
   <td style="border:none;" align="left">20070614</td>
   <td style="border:none;" align="left">Five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics</td>
   <td style="border:none;" align="left">Academia Sinica, Taiwan</td>
  </tr>
 </tbody>
</table>
